SCHEMBL22019152

SCHEMBL22019152

O=C(c1cccc(C(F)(F)F)c1)c1cnc(N2CCCC(C(F)(F)F)C2)s1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
VNN1 O95497 1/20 0.44
ALDH1A1 P00352 2/20 0.42
SCD O00767 1/20 0.42
LMNA P02545 3/20 0.41
KDM4E B2RXH2 3/20 0.41
USP2 O75604 1/20 0.41
ALOX15 P16050 1/20 0.41
TSHR P16473 1/20 0.41
HSD17B10 Q99714 1/20 0.41
HPGD P15428 2/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
GAA P10253 1/20 0.41
POLB P06746 1/20 0.41
UBE2N P61088 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
SCN10A Q9Y5Y9 1/20 0.41
RAF1 P04049 1/20 0.41
BRAF P15056 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21962681 1.00 VNN1 (0.44) VNN1ALDH1A1SCDLMNAKDM4E
SCHEMBL22019585 0.91 VNN1 (0.44) VNN1ALDH1A1SCDLMNAKDM4E
SCHEMBL21962851 0.91 VNN1 (0.44) VNN1ALDH1A1SCDLMNAKDM4E
SCHEMBL21962552 0.89 IDH2 (0.48) VNN1ALDH1A1SCDLMNAKDM4E
SCHEMBL21962458 0.88 SCD (0.46) VNN1ALDH1A1SCDLMNAKDM4E
SCHEMBL21962779 0.86 MLYCD (0.49) ALDH1A1SCDLMNAKDM4EHSD17B10
SCHEMBL21962568 0.86 LMNA (0.51) ALDH1A1SCDLMNAKDM4EHSD17B10
SCHEMBL21962542 0.86 RAF1 (0.48) VNN1ALDH1A1SCDLMNAKDM4E
SCHEMBL22019591 0.85 LMNA (0.53) SCDLMNAKDM4EHPGDPOLB
SCHEMBL21962446 0.85 SCD (0.46) VNN1ALDH1A1SCDKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020102575-A1 HETEROCYCLIC AMINOTHIAZOLES AND USES THEREOF INCEPTION IBD, INC. (US) 2020-05-22 WO disclosed